The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective.
Journal Information
Full Title: Ther Adv Endocrinol Metab
Abbreviation: Ther Adv Endocrinol Metab
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology & Metabolism
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement: WP and DA are employees of Novo Nordisk.: CF is an employee of DRG Abacus (sponsored by Novo Nordisk).: LL reports having received speaker honoraria from Minimed Medtronic, Animas, Roche, Sanofi and Novo Nordisk, and serving on advisory panels for Minimed Medtronic, Animas, Roche and Novo Nordisk."
"Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025